MIT News reported June 18 that Feng Zhang, a core institute member of the Broad Institute, an investigator at the McGovern Institute for Brain Research at MIT, has been named a 2016 Tang Prize Laureate in Biopharmaceutical Science for his role in developing the CRISPR-Cas9 gene-editing system and demonstrating pioneering uses in eukaryotic cells.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Film festival on human rights and freedom set to begin Saturday
05/03/2024 08:39 PM - Politics
Legislature advances amendment that seeks review of power rate change
05/03/2024 07:22 PM - Culture
Penghu fireworks festival opens, starting eventful tourist season
05/03/2024 06:59 PM - Sports
T1 LEAGUE playoffs to kick off Saturday
05/03/2024 06:51 PM - Culture
Taiwanese artists hold modern ink painting exhibition in Bangkok
05/03/2024 06:41 PM